Remarkably, we found a high mutation rate of PTCH1 in Taiwanese breast cancer patients (3.70% in our series vs. 0.91% in COSMIC, Fig. 1B, or 1.39% in TCGA, Supplementary Fig. S1). Here, PTCH1 is linked to breast carcinoma.